Adenosine triphosphate inhibits cytokine release from lipopolysaccharide-activated microglia via P2y receptors
- PMID: 12885439
- DOI: 10.1016/s0006-8993(03)03028-2
Adenosine triphosphate inhibits cytokine release from lipopolysaccharide-activated microglia via P2y receptors
Abstract
Microglial proliferation and activation have been reported to occur after several central nervous system injuries. In this study, we tested the effects of adenosine triphosphate (ATP) on cultured microglia obtained from the spinal cord of rat embryos. The amounts of tumor necrosis factor alpha (TNF-alpha), interleukin 1beta and interleukin 6 released from the microglia, which were stimulated by lipopolysaccharide (LPS; 100 ng/ml), were inhibited by the simultaneous addition of ATP in a dose dependent manner (10-300 microM). We examined the effect of several endogenous purines (ATP, ADP, CTP, UDP, UTP) and P(2)y receptor agonists (ADPbetaS and 2-methylthio-ATP) on LPS-induced TNF-alpha release. The rank order of inhibitory potency of endogenous purines on TNF-alpha release was: ATP>ADP>>UTP>UDP>CTP. The latter three were much less potent than the former two. The addition of 10 microM 2-methylthio-ATP showed a potency similar to 100 microM ATP. The addition of ADPbetaS, however, showed less effect. These endogenous purines and selective ATP receptor agonists showed a similar inhibitory effect in their rank order on LPS-induced interleukin 6 release. We demonstrate that ATP inhibits cytokine release from LPS-activated microglia via metabotropic receptors. The application of P(2)y receptor agonists might be considered as a pharmacological treatment of several pathological conditions of the spinal cord, including toxic immunoreactions.
Similar articles
-
Effect of purinergic agonists and antagonists on insulin secretion from INS-1 cells (insulinoma cell line) and rat pancreatic islets.Can J Physiol Pharmacol. 2002 Jun;80(6):562-8. doi: 10.1139/y02-079. Can J Physiol Pharmacol. 2002. PMID: 12117305
-
Bi-functional effects of ATP/P2 receptor activation on tumor necrosis factor-alpha release in lipopolysaccharide-stimulated astrocytes.J Neurochem. 2005 Feb;92(3):525-35. doi: 10.1111/j.1471-4159.2004.02885.x. J Neurochem. 2005. PMID: 15659223
-
Cross talk between P2 purinergic receptors modulates extracellular ATP-mediated interleukin-10 production in rat microglial cells.Exp Mol Med. 2008 Feb 29;40(1):19-26. doi: 10.3858/emm.2008.40.1.19. Exp Mol Med. 2008. PMID: 18305394 Free PMC article.
-
Microglia and the Purinergic Signaling System.Neuroscience. 2019 May 1;405:137-147. doi: 10.1016/j.neuroscience.2018.12.021. Epub 2018 Dec 21. Neuroscience. 2019. PMID: 30582977 Review.
-
Microglial activation by purines and pyrimidines.Glia. 2002 Nov;40(2):156-163. doi: 10.1002/glia.10150. Glia. 2002. PMID: 12379903 Review.
Cited by
-
Resident immune responses to spinal cord injury: role of astrocytes and microglia.Neural Regen Res. 2024 Aug 1;19(8):1678-1685. doi: 10.4103/1673-5374.389630. Epub 2023 Dec 11. Neural Regen Res. 2024. PMID: 38103231 Free PMC article.
-
P2Y14 receptor activation decreases interleukin-6 production and glioma GL261 cell proliferation in microglial transwell cultures.J Neurooncol. 2018 Mar;137(1):23-31. doi: 10.1007/s11060-017-2700-9. Epub 2017 Nov 30. J Neurooncol. 2018. PMID: 29189936 Free PMC article.
-
Purinergic signaling and microglia.Pflugers Arch. 2006 Aug;452(5):615-21. doi: 10.1007/s00424-006-0064-7. Epub 2006 Jun 21. Pflugers Arch. 2006. PMID: 16791619 Review.
-
Microglial phenotype and adaptation.J Neuroimmune Pharmacol. 2013 Sep;8(4):807-23. doi: 10.1007/s11481-013-9490-4. Epub 2013 Jul 25. J Neuroimmune Pharmacol. 2013. PMID: 23881706 Review.
-
The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brain.Front Cell Neurosci. 2014 Sep 1;8:260. doi: 10.3389/fncel.2014.00260. eCollection 2014. Front Cell Neurosci. 2014. PMID: 25225473 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources